Overview

Effects of Iron Supplements on the Pharmacokinetics of MT-6548

Status:
Completed
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
The objectives of this study are to investigate the pharmacokinetics and safety of MT-6548 co-administered with iron supplements in healthy male volunteers.
Phase:
Phase 3
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation
Treatments:
Iron